BioPoly® Oversubscribes $2M Private Equity Offering
December 18, 2019
BioPoly, LLC announced today that it has fully subscribed its latest round of private equity financing of $2M. The financing round also includes oversubscription funding of $890k.
BioPoly® Granted Another US Patent
December 3, 2019
BioPoly LLC has announced that another U.S. patent has been granted for its innovative BioPoly® material, which is currently being used to replace damaged cartilage in joints.
BioPoly® Granted US Patent
October 17, 2019
FORT WAYNE, IN – BioPoly LLC has announced that another U.S. patent has been granted for its partial resurfacing implants.
BioPoly Signs Exclusive Distribution Agreement with Hospital Innovations in the UK
July 24, 2019
FORT WAYNE, IN – BioPoly, LLC has entered into an exclusive distribution agreement with UK-based distributor, Hospital Innovations Ltd, to distribute the BioPoly® partial resurfacing family of products throughout the UK.
BioPoly® Granted European Patent for Its Innovative Implant Design
January 9, 2019
FORT WAYNE, IN – BioPoly LLC has announced that another European patent has been granted for its partial resurfacing implants. Where many of the other BioPoly® patents address the unique material, this patent family focuses on the innovative implant designs.
BioPoly® Announces FDA Approval to Initiate Pivotal Clinical Study for Treatment of Cartilage Defects of the Knee
November 16, 2018
FORT WAYNE, IN – BioPoly has just announced that the US FDA has approved an IDE clinical study for its BioPoly® RS Partial Resurfacing Knee System. The BioPoly knee is used to treat patients with painful cartilage lesions by filling the defect with its proprietary implant material known as BioPoly. According to the Company, initiation of the clinical study in the US will happen soon.